Promisia Healthcare Limited

As of March 31, 2026, Promisia Healthcare Limited carries a market capitalization of 24.78M, placing it among publicly traded companies globally. Its enterprise value stands at 154.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Promisia Healthcare Limited has 52.73M shares outstanding.

As of March 31, 2026, Promisia Healthcare Limited trades at a trailing price-to-earnings ratio of 1.92. The price-to-sales ratio is 0.65, and the price-to-book ratio stands at 0.45.

As of March 31, 2026, Promisia Healthcare Limited trades at an EV/EBITDA multiple of 37.68 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 43.12 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 154.85M versus a market cap of 24.78M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Promisia Healthcare Limited maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 235.82, indicating elevated leverage, while an interest coverage ratio of 1.15 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Promisia Healthcare Limited posted a return on equity (ROE) of 27.36, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.91 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.96, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.37, useful for judging operating efficiency across full business cycles. The company generates approximately 81,062.10 in revenue per employee across its workforce of 467.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, Promisia Healthcare Limited recorded 1.02M in income tax expense. That works out to an effective tax rate of 7.30, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 13.94M, leaving 12.92M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Promisia Healthcare Limited's stock has gained approximately 45.05% over the past 52 weeks. The 50-day moving average sits at 0.69, while the 200-day moving average is 0.58.

Over the twelve months ended March 31, 2026, Promisia Healthcare Limited generated 37.86M in revenue and converted that into 12.92M in net income, yielding earnings per share of 0.21. EBITDA reached 4.11M, while operating income came in at 3.63M.

As of March 31, 2026, Promisia Healthcare Limited holds 110,000.00 in cash and equivalents against 130.18M in total debt, resulting in a net debt position of 41.41M. Total book value stands at 55.20M, with working capital of -139.50M providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

These figures cover the twelve months ended March 31, 2026. The operating margin of 9.58 and net profit margin of 34.14 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Total shareholder yield reaches 26.25, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Promisia Healthcare Limited shareholders.

Promisia Healthcare Limited's most recent stock split took place on September 27, 2024 with a 500:1 split ratio.

As of March 31, 2026, Promisia Healthcare Limited has an Altman Z-Score of -0.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.